First-time generic approvals July 2010
Generic drugs approved by FDA (through June 2010): Venlafaxine hydrochloride extended-release capsules, Meropenem for injection, Adapalene 0.1% gel, Aztreonam for injection, Oxaliplatin for injection
Venlafaxine hydrochloride extended-release capsules (equiv to Effexor XR) in 37.5-mg, 75-mg, and 150-mg strengths
TEVA
Meropenem for injection (equiv to Merrem) in 500-mg and 1-g vials
Adapalene 0.1% gel (equiv to Differin)
TEVA
Aztreonam for injection (equiv to Azactam) in single-dose vials of 1 g, 20 mL and 2 g, 30 mL
APP PHARMACEUTICALS
Oxaliplatin for injection (lyophilized) (equiv to Eloxatin), 50 mg and 100 mg
APP PHARMACEUTICALS
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
